Načítá se...
Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies
Advances in the treatment of rheumatoid arthritis (RA) are attributed to several aspects such as new classification criteria enabling early diagnosis and intensive treatment with the application of treat-to-target principles as well as better understanding of the pathogenesis of RA contributing to t...
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000 Research Limited
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719675/ https://ncbi.nlm.nih.gov/pubmed/31508202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.18688.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|